KidneyCare Guided Immuno-Optimization in Renal Allografts: The KIRA Protocol
Open Access
- 30 September 2020
- journal article
- protocol
- Published by MDPI AG in Methods and Protocols
- Vol. 3 (4), 68
- https://doi.org/10.3390/mps3040068
Abstract
Immunosuppressant agents are essential in every transplant recipient’s care yet walking the fine line of over- or under-immunosuppression is a constant struggle for both patients and transplant providers alike. Optimization and personalization of immunosuppression has been limited by the need for non-invasive graft surveillance methods that are specific enough to identify organ injury in real time. With this in mind, we propose a pilot study protocol utilizing both donor derived cell free DNA (dd-cfDNA, gene expression profiling (GEP), and machine learning (iBox), called KidneyCare, to assess the feasibility and safety in reducing immunosuppressant exposure without increasing the risk of clinical rejection, graft injury, or allograft loss. Patients randomized to the immunominimization arm will be enrolled in one of two protocols designed to eliminate one immunosuppressant and optimize the dose of the Calcineurin Inhibitors (CNIs) using the KidneyCare platform. All patients will be maintained on dual therapy of either steroids and a low dose CNI, or mycophenolate mofetil (MMF) and low dose CNI. Their outcomes will be compared to patients who have their immunosuppressants managed using standard clinical assessment and treatment protocols to determine the impact of immuno-optimization on graft function, complications, and patient reported outcomes.This publication has 19 references indexed in Scilit:
- Molecular Classifiers for Acute Kidney Transplant Rejection in Peripheral Blood by Whole Genome Gene Expression ProfilingAmerican Journal of Transplantation, 2014
- Tacrolimus-Based, Steroid-Free Regimens in Renal TransplantationTransplantation, 2012
- Minimizing the Risk of Chronic Allograft NephropathyTransplantation, 2009
- New-Onset Diabetes after Kidney TransplantationJournal of the American Society of Nephrology, 2006
- Population‐based assessment of adverse events associated with long‐term glucocorticoid useArthritis Care & Research, 2006
- Maintenance Immunosuppression Regimens: Conversion, Minimization, Withdrawal, and AvoidanceAmerican Journal of Kidney Diseases, 2006
- Myeloperoxidase as a Marker of Hemodialysis Biocompatibility and Oxidative Stress: The Underestimated Modifying Effects of HeparinAmerican Journal of Kidney Diseases, 2006
- Immunosuppression: evolution in practice and trends, 1993–2003American Journal of Transplantation, 2005
- Steroid Withdrawal in Renal Transplant Patients on Triple Therapy with a Calcineurin Inhibitor and Mycophenolate Mofetil: A Meta-analysis of Randomized, Controlled TrialsTransplantation, 2004
- Chronic Renal Failure after Transplantation of a Nonrenal OrganThe New England Journal of Medicine, 2003